Anti-HGFR / c-Met Reference Antibody (telisotuzumab vedotin) CHB249
The add to cart button will appear once you select the values above
Specifications
| 100 μg / 1 mg |
Description:
Telisotuzumab vedotin is an ADC consisting of a cMET-directed antibody and Monomethyl auristatin E (MMAE) that has recently obtained the breakthrough therapy designation (BTD) for the treatment of patients with c-Met overexpression, advanced/metastatic wild-type (WT) epithelial growth factor receptor (EGFR) non-squamous non-small cell lung cancer (sqNSCLC) that progressed during or after platinum-based chemotherapy.
Product type:
Antibody
Host:
CHO
Target name:
HGFR / c-Met
Target species:
Human
Isotype:
IgG
Buffer:
100 mM Pro-Ac 20 mM Arg pH5.0
Applications:
ELISA、FACS、Kinetics (BLI)、Kinetics (SPR)、Functional assay
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com